Position in HLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$186,926
+$38,748 QoQ
Shares Held
20,035
+35.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#298
of 639 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Frec Markets, Inc. holds $3,218,897 across 8 Drug Manufacturers - Specialty & Generic names. HLN ranks #8 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
11,483 | $825,168 | |
| 2 | VTRS |
Viatris Inc
|
35,669 | $566,423 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
3,083 | $519,608 | |
| 4 | DERM |
Journey Medical Corp
|
50,500 | $357,540 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
626 | $339,185 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
9,204 | $226,510 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
12,323 | $197,537 | |
| 8 | HLN |
Haleon plc
This page
|
20,035 | $186,926 |
All Filings in HLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $186,926 | 20,035 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $148,178 | 14,803 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $121,148 | 11,983 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||